trovafloxacin has been researched along with Pneumonia, Pneumococcal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champlin, J; Pullman, J; Vrooman, PS | 1 |
| Azoulay-Dupuis, E; Bédos, JP; Cherbuliez, C; Fantin, B; Isturiz, R; Köhler, T; Mohler, J; Moine, P; Péchère, JC; Peytavin, G; Rieux, V | 1 |
| Gentry-Nielsen, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Courvalin, P; Girard, D; Gootz, TD; Haskell, S; Polzer, RJ; Schmieder, B; Tankovic, J; Zaniewski, R | 1 |
| Gootz, TD; Klugman, KP | 1 |
| Daniel, R; de Kock, F; Pluck, N; Trémolières, F | 1 |
| Gentry, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Friedland, IR; Ghaffar, F; Jafri, H; Lutsar, I; McCracken, GH; Ng, W; Wubbel, L | 1 |
| Alcantára, R; Alvarez, A; Andrade, RJ; Camargo, R; Lopez-Garrido, MJ; Lucena, MI; Rodrigo, L; Salmerón, J | 1 |
| Friedland, IR; Ghaffar, F; Jafri, H; Lutsar, I; McCracken, GH; Ng, W; Olsen, K; Wubbel, L | 1 |
2 trial(s) available for trovafloxacin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Ketolides; Macrolides; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Risk Factors; Treatment Outcome | 2003 |
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
8 other study(ies) available for trovafloxacin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Topics: Animals; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Lung; Mice; Microbial Sensitivity Tests; Naphthyridines; Phenotype; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Survival Analysis | 2004 |
Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
Topics: Animals; Azithromycin; Biological Availability; Blood Chemical Analysis; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Injections, Subcutaneous; Liver Cirrhosis; Male; Naphthyridines; Pneumonia, Pneumococcal; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate | 2005 |
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Gene Amplification; Genes, Bacterial; Mice; Microbial Sensitivity Tests; Mutation; Naphthyridines; Pneumonia, Pneumococcal; Sequence Analysis, DNA; Streptococcus pneumoniae; Topoisomerase II Inhibitors | 1996 |
In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae | 1997 |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Ethanol; Feeding Behavior; Fluoroquinolones; Leukocyte Count; Male; Naphthyridines; Neutrophils; Pneumonia, Pneumococcal; Rats; Rats, Sprague-Dawley | 1999 |
Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Naphthyridines; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1999 |
Trovafloxacin-induced acute hepatitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Fluoroquinolones; Humans; Liver Function Tests; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Prognosis; Respiratory Tract Infections | 2000 |
Buffy coat PCR for diagnosis of experimental pneumococcal pneumonia.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Blood; Colony Count, Microbial; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred BALB C; Naphthyridines; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Predictive Value of Tests; Rabbits; Sensitivity and Specificity; Streptococcus pneumoniae; Streptolysins | 2000 |